This knowledge platform, which includes an extensive set of (proprietary) TCR data, can be used for predicting response to therapies, monitoring the efficacy of therapies, early detection of cancer, and vaccine development. These are just a few examples of the many uses of the knowledge platform. The renowned team, made up of leading researchers and engineers, aims to use the platform to enable the advancement of new therapeutic discoveries and help discover new treatments.

Diseases can develop unnoticed and are often only detected when the first symptoms appear. Early detection not only increases treatment options, but also the chances of recovery. The background for the use of immune data is that the human immune system is able to detect diseases in advance and to target its reaction against the different disease targets.An immune reaction is a response of the entire system that dynamically detects and quantifies the disease. The goal of Synteny's technology is to use data from the immune receptor repertoire to create an accurate picture of the disease state in real time. Computational tools enable the repertoire to be used to learn disease-specific signals and to develop and adapt therapies and treatments at an early stage.